Catheter Precision, Inc. (NYSE/American:VTAK), a company dedicated in the development and marketing of technologically advanced products for the cardiac electrophysiology market, today announced ...
KP.3.1.1 and LB.1 in vitro neutralization potency values now reflected in the PEMGARDA Fact Sheet for Healthcare Providers are in-line with prior ...
Coventry's Citizen Advice has opened its new office in Foleshill that brings back face-to-face drop-in support for the first time since the pandemic. The bureau provides residents with direct ...
Violent crime in Coventry city centre saw a substantial fall this summer according to police bosses. West Midlands Police and Crime Commissioner Simon Foster says the 10 per cent reduction ...
Wall Street analysts and state financial monitors are raising questions about the fiscal health of Coventry as its school system grapples with growing debt. Days after Moody's canceled Coventry's ...
Editor’s note: The FDA has issued a similar warning for some Answers brand pet food. The manufacturer, Lystn LLC, has not issued a recall, despite the Food and Drug Administration’s testing ...
Amid an ongoing pet food recall, the U.S. Food and Drug Administration (FDA) is urging pet owners not to give their dogs and cats certain food products from two different brands. Both the brands ...
Bereaved families have shared stories about their loved ones who gave "the gift of life" by donating their organs. Four people received organs from Adrian Foster's wife Phillipa after she died ...
The U.S. Food and Drug Administration (FDA) on Thursday approved Cobenfy (xanomeline and trospium chloride), developed by Bristol-Myers Squibb (NYSE:BMY), as a novel treatment for adults with the ...
The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated schizophrenia drug, Cobenfy. It’s the first novel treatment for the ...
26, when the U.S. Food and Drug Administration (FDA) approved Cobenfy for the psychiatric disorder. Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb ...
On Thursday, the U.S. Food and Drug Administration (FDA) approved COBENFY (xanomeline and trospium chloride), an oral medication that is manufactured by Bristol Myers Squibb in New Jersey.